Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|June 16, 2022
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future researchMarco Palla, Luigi Scarpato, Rossella Di Trolio, et al.Skinmed|May 8, 2007
Granuloma faciale with extrafacial lesionsLuigi Rossiello, Marco Palla, Francesco Saviero Aiello, et al.ISRN Dermatology|May 28, 2013
The role of optical radiations in skin cancerFabrizio Ayala, Marco Palla, Rossella Di Trolio, et al.Discovery Medicine|July 16, 2015
Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathwayAntonio Maria Grimaldi, Ester Simeone, Lucia Festino, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 7, 2017
Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of CareEster Simeone, Antonio M Grimaldi, Lucia Festino, et al.Expert Opinion on Drug Safety|October 1, 2021
Dermatologic adverse events associated with targeted therapies for melanomaLuigi Scarpato, Lucia Festino, Vito Vanella, et al.Cancer Immunology, Immunotherapy : CII|September 9, 2016
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trialPaolo A Ascierto, Vito Vanella, Antonio Maria Grimaldi, et al.Journal of Medical Case Reports|July 3, 2014
Serious haematological toxicity during and after ipilimumab treatment: a case seriesEster Simeone, Antonio Maria Grimaldi, Assunta Esposito, et al.Skinmed|January 12, 2007
Sporotrichosis: success of itraconazole treatmentAdone Baroni, Marco Palla, Maria Rosaria Iovene, et al.Melanoma Management|December 25, 2019
Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their managementEster Simeone, Antonio M Grimaldi, Lucia Festino, et al.Pageof 4